Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Early histological advantage of CD271-positive adipose-derived mesenchymal stromal cells isolated from the infrapatellar fat pad in experimental knee osteoarthritis.

Sakamoto T., Aoki N., Shiotani T., Kitade M., Noguchi T., Saito S.

Laboratory Study on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
BMC Musculoskelet Disord (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42477654
DOI
10.1186/s12891-026-10249-6

Abstract (original English)

Background Mesenchymal stromal cells (MSCs) have been increasingly explored as a minimally invasive treatment for osteoarthritis (OA), primarily due to their anti-inflammatory, immunomodulatory, and analgesic properties. However, MSC populations are biologically heterogeneous, and optimal cell phenotypes for intra-articular therapy remain unclear. CD271 has been identified as a marker associated with MSC subpopulations with enhanced regenerative potential. The aim of this study is to evaluate whether intra-articular injection of phenotype-selected CD271-positive adipose-derived MSCs (AD-MSCs) provides additional structural benefits compared with unselected AD-MSCs in experimental OA. Methods OA was induced in athymic rats by intra-articular injection of monoiodoacetate. Human infrapatellar fat pad-derived AD-MSCs were isolated and separated into CD271-positive fractions using magnetic-activated cell sorting. One week after OA induction, animals received intra-articular injection of saline, plastic-adherent AD-MSCs (PA-AD-MSCs), or CD271-positive AD-MSCs. Cartilage degeneration was assessed macroscopically and histologically using the Histologic/Histochemical Grading System (HHGS). Pain-related neuropeptides in dorsal root ganglia were analyzed by immunohistochemistry, and synovial inflammatory cytokines were quantified by ELISA. Results Both MSC-treated groups showed significan

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research